Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 640

Sort by

Sort Order Select

Journal Articles

Thrombophilia management calculator

Iztok Hozo, Benjamin Djulbegovic

Blood Adv (2024) 8 (15): 3914–3916.

https://doi.org/10.1182/bloodadvances.2024013463

Published: 2024

Includes: Supplemental data

Journal Articles

The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential

Yuto Nakajima, Akihisa Oda, Nemekhbayar Baatartsogt, Yuji Kashiwakura, Tsukasa Ohmori, Keiji Nogami

Blood Adv (2024) 8 (15): 3929–3940.

https://doi.org/10.1182/bloodadvances.2023012391

Published: 2024

Includes: Supplemental data

Journal Articles

Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B

Meng Gao, Long Chen, Jinlong Yang, Shixia Dong, Qing Cao, Zihan Cui, Yanyan Dong, Hongli Liu, Yan Shen, Haiping Yang, Zhenyu Hao, Lei Zhang, Weikai Li, Jian-Ke Tie, Guomin Shen

Blood Adv (2024) 8 (15): 3893–3905.

https://doi.org/10.1182/bloodadvances.2023012432

Published: 2024

Includes: Supplemental data

Journal Articles

Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer

Rui-Gang Xu, Christian Tiede, Antonio N. Calabrese, Lih T. Cheah, Thomas L. Adams, Julia S. Gauer, Matthew S. Hindle, Beth A. Webb, Daisie M. Yates, Alexandre Slater, Cédric Duval, Khalid M. Naseem, Andrew B. Herr, Darren C. Tomlinson, Steve P. Watson, Robert A. S. Ariëns

Blood Adv (2024) 8 (15): 3917–3928.

https://doi.org/10.1182/bloodadvances.2024012689

Published: 2024

Includes: Supplemental data

Journal Articles

Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice

Gagan D. Flora, Madankumar Ghatge, Manasa K. Nayak, Tarun Barbhuyan, Mariia Kumskova, Anil K. Chauhan

Blood Adv (2024) 8 (15): 3906–3913.

https://doi.org/10.1182/bloodadvances.2024013199

Published: 2024

Includes: Supplemental data

Journal Articles

Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy

Simon Dadoun, Karolina Adam, Lisa Hensch, Theonia K. Boyd, Sami Ibrahimi, James N. George, Marie Scully, Senthil Sukumar

Blood Adv (2024) 8 (14): 3718–3720.

https://doi.org/10.1182/bloodadvances.2024013265

Published: 2024

Journal Articles

Packaging of supplemented urokinase into alpha granules of in vitro–grown megakaryocytes for targeted nascent clot lysis

Mortimer Poncz, Sergei V. Zaitsev, Hyunsook Ahn, M. Anna Kowalska, Khalil Bdeir, Konstantin V. Dergilev, Lacramioara Ivanciu, Rodney M. Camire, Douglas B. Cines, Victoria Stepanova

Blood Adv (2024) 8 (14): 3798–3809.

https://doi.org/10.1182/bloodadvances.2024012835

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

Anticoagulation for the treatment of immune checkpoint inhibitor-associated venous thromboembolism

Cho Han Chiang, Soravis Osataphan, Yu-Cheng Chang, Kuan-Yu Chi, Cho-Hung Chiang, Yu Chang, Rushad Patell

Blood Adv bloodadvances.2024013869.

https://doi.org/10.1182/bloodadvances.2024013869

Published: 2024

Includes: Supplemental data

Journal Articles

D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation

Armando Tripodi, Marco Capecchi, Erica Scalambrino, Marigrazia Clerici, Barbara Scimeca, Pasquale Agosti, Paolo Bucciarelli, Flora Peyvandi

Blood Adv (2024) 8 (14): 3612–3614.

https://doi.org/10.1182/bloodadvances.2024013193

Published: 2024

Journal Articles

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines

Benjamin Djulbegovic, Iztok Hozo, Gordon Guyatt

Blood Adv (2024) 8 (13): 3596–3606.

https://doi.org/10.1182/bloodadvances.2024012931

Published: 2024

Includes: Supplemental data

Journal Articles

LMWH prevents thrombo-inflammation in the placenta via HBEGF-AKT signalling

Kunal Kumar Singh, Anubhuti Gupta, Désirée Forstner, PhD, Jacqueline Guettler, Mirjam Susanne Ahrens, Akshay Prakasan Sheeja, Sameen Fatima, Saikal Shamkeeva, Massimiliano Lia, Anne Dathan-Stumpf, Nikola Hoffmann, Khurrum Shahzad, Holger Stepan, Martin Gauster, Berend Isermann, Shrey Kohli

Blood Adv bloodadvances.2023011895.

https://doi.org/10.1182/bloodadvances.2023011895

Published: 2024

Includes: Supplemental data

Journal Articles

Global Prevalence of Hereditary Thrombotic Thrombocytopenic Purpura Determined by Genetic Analysis

Omid Seidizadeh, Andrea Cairo, Ilaria Mancini, James N George, Flora Peyvandi

Blood Adv bloodadvances.2024013421.

https://doi.org/10.1182/bloodadvances.2024013421

Published: 2024

Includes: Supplemental data

Journal Articles

Essential role of glycoprotein Ibα in platelet activation

Rong Yan, Yue Xia, Kangxi Zhou, Jun Liu, Yueyue Sun, Chunyan He, Xinxin Ge, Mengnan Yang, Chenglin Sun, Liuxia Yuan, Shujun Li, Biao Yang, Fanbi Meng, Lijuan Cao, Changgeng Ruan, Kesheng Dai

Blood Adv (2024) 8 (13): 3388–3401.

https://doi.org/10.1182/bloodadvances.2023012308

Published: 2024

Includes: Supplemental data

Journal Articles

Exacerbation of thromboinflammation by JAK2 V617F mutation worsens the prognosis of cerebral venous sinus thrombosis

Blood Adv (2024) 8 (12): 3330–3343.

https://doi.org/10.1182/bloodadvances.2023011692

Published: 2024

Includes: Multimedia, Supplemental data

Journal Articles

Blood cell JAKtivation aggravates cerebral venous thrombosis

Brandi Reeves

Blood Adv (2024) 8 (12): 3327–3329.

https://doi.org/10.1182/bloodadvances.2024012977

Published: 2024

Journal Articles

Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis

Benjamin Djulbegovic, Alice Boylan, Shelby Kolo, Danielle Bowen Scheurer, Sydney Anuskiewicz, Flora Khaledi, Kimberley Youkhana, Sarah Madgwick, Neema Maharjan, Iztok Hozo

Blood Adv (2024) 8 (12): 3214–3224.

https://doi.org/10.1182/bloodadvances.2024013166

Published: 2024

Includes: Supplemental data

Journal Articles

Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease

Nirupama Ramadas, Kailyn Lowder, Joshua Dutton, Fatima Trebak, Camille Faes, John H. Griffin, Rafal Pawlinski, Laurent O. Mosnier, Erica Sparkenbaugh

Blood Adv (2024) 8 (12): 3272–3283.

https://doi.org/10.1182/bloodadvances.2023011907

Published: 2024

Includes: Supplemental data

Journal Articles

O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies

Ellie Karampini, Dearbhla Doherty, Petra E. Bürgisser, Massimiliano Garre, Ingmar Schoen, Stephanie Elliott, Ruben Bierings, James S. O’Donnell

Blood Adv (2024) 8 (12): 3254–3266.

https://doi.org/10.1182/bloodadvances.2023012499

Published: 2024

Journal Articles

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women

Ellen Zhang, Zain M. Virk, Josanna Rodriguez-Lopez, Hanny Al-Samkari

Blood Adv (2024) 8 (12): 3166–3172.

https://doi.org/10.1182/bloodadvances.2023011961

Published: 2024

Includes: Supplemental data

Journal Articles

Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis

Barbara D. Lam, Pavlina Chrysafi, Thita Chiasakul, Harshit Khosla, Dimitra Karagkouni, Megan McNichol, Alys Adamski, Nimia Reyes, Karon Abe, Simon Mantha, Ioannis S. Vlachos, Jeffrey I. Zwicker, Rushad Patell

Blood Adv (2024) 8 (12): 2991–3000.

https://doi.org/10.1182/bloodadvances.2023012200

Published: 2024

Includes: Supplemental data

NARROW

Thrombophilia management calculator

The combination of Asp519Val/Glu665Val and Lys1813Ala mutations in FVIII markedly increases coagulation potential

Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B

Affimer reagents as tool molecules to modulate platelet GPVI-ligand interactions and specifically bind GPVI dimer

Deletion of pyruvate dehydrogenase kinases reduces susceptibility to deep vein thrombosis in mice

Recombinant ADAMTS13: an effective rescue therapy for acute cTTP during pregnancy

Packaging of supplemented urokinase into alpha granules of in vitro–grown megakaryocytes for targeted nascent clot lysis

Anticoagulation for the treatment of immune checkpoint inhibitor-associated venous thromboembolism

D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation

Decision theoretical foundations of clinical practice guidelines: an extension of the ASH thrombophilia guidelines

LMWH prevents thrombo-inflammation in the placenta via HBEGF-AKT signalling

Global Prevalence of Hereditary Thrombotic Thrombocytopenic Purpura Determined by Genetic Analysis

Essential role of glycoprotein Ibα in platelet activation

Exacerbation of thromboinflammation by JAK2 V617F mutation worsens the prognosis of cerebral venous sinus thrombosis

Blood cell JAKtivation aggravates cerebral venous thrombosis

Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis

Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease

O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women

Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only